3.8 Article

Estimated incidence of respiratory hospitalizations attributable to RSV infections across age and socioeconomic groups

Journal

PNEUMONIA
Volume 14, Issue 1, Pages -

Publisher

BMC
DOI: 10.1186/s41479-022-00098-x

Keywords

-

Funding

  1. National Institute of Allergy and Infectious Diseases (MIDAS Program) of the National Institutes of Health [R01AI137093]

Ask authors/readers for more resources

Respiratory syncytial virus (RSV) causes a significant burden of hospitalization in the US, particularly among infants and older adults. The incidence is higher among infants of low socioeconomic status and varies among different socioeconomic groups. Recorded diagnoses underestimate the incidence of RSV hospitalization, especially in older adults.
Background Surveillance for respiratory syncytial virus (RSV) likely captures just a fraction of the burden of disease. Understanding the burden of hospitalizations and disparities between populations can help to inform upcoming RSV vaccine programs and to improve surveillance. Methods We obtained monthly age-, ZIP code- and cause-specific hospitalizations in New York, New Jersey, and Washington from the US State Inpatient Databases (2005-2014). We estimated the incidence of respiratory hospitalizations attributable to RSV by age and by socioeconomic status using regression models. We compared the estimated incidence and the recorded incidence (based on ICD9-CM) of RSV hospitalizations to estimate the under-recorded ratio in different subpopulations. Results The estimated annual incidence of respiratory hospitalizations due to RSV was highest among infants < 1 year of age with low socioeconomic status (2800, 95% CrI [2600, 2900] per 100,000 person-years). We also estimated a considerable incidence in older adults (>= 65 years of age), ranging from 130 to 960 per 100,000 person-years across different socioeconomic strata. The incidence of hospitalization recorded as being due to RSV represented a significant undercount, particularly in adults. Less than 5% of the estimated RSV hospitalizations were captured for those >= 65 years of age. Conclusions RSV causes a considerable burden of hospitalization in young children and in older adults in the US, with variation by socioeconomic group. Recorded diagnoses substantially underestimate the incidence of hospitalization due to RSV in older adults.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Infectious Diseases

One health insights to prevent the next HxNy viral outbreak: learning from the epidemiology of H7N9

Zhe Zheng, Yi Lu, Kirsty R. Short, Jiahai Lu

BMC INFECTIOUS DISEASES (2019)

Article Medicine, General & Internal

Clinical indices and mortality of hospitalized avian influenza A (H7N9) patients in Guangdong, China

Yang Yang, Xue Li, Guthrie S. Birkhead, Zhe Zheng, Jia-hai Lu

CHINESE MEDICAL JOURNAL (2019)

Article Multidisciplinary Sciences

Community factors associated with local epidemic timing of respiratory syncytial virus: A spatiotemporal modeling study

Zhe Zheng, Virginia E. Pitzer, Joshua L. Warren, Daniel M. Weinberger

Summary: The study found that respiratory syncytial virus epidemics exhibit spatial-temporal variability, with earlier epidemics associated with larger household size and higher population density. Nearby localities had similar epidemic timings, suggesting that epidemics grow faster in areas with more local contact opportunities and follow a spatial diffusion process based on geographic proximity.

SCIENCE ADVANCES (2021)

Article Infectious Diseases

Relative timing of respiratory syncytial virus epidemics in summer 2021 across the United States was similar to a typical winter season

Zhe Zheng, Joshua L. Warren, Iris Artin, Virginia E. Pitzer, Daniel M. Weinberger

Summary: This study used Google search data as a validated proxy to evaluate the onset of RSV epidemics in 2021 and 2016-2019. Despite the unusual occurrence of RSV epidemics in summer, the relative timing of RSV epidemics between states in 2021 showed similarities with typical winter seasons. The findings suggest that the onset of RSV epidemics in Florida can be used as a baseline for adjusting prophylaxis administration and clinical trial initiation in other states, regardless of the seasonality of RSV epidemics.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2022)

Article Immunology

Predicted effectiveness of vaccines and extended half-life monoclonal antibodies against RSV hospitalizations in children

Zhe Zheng, Daniel M. Weinberger, Virginia E. Pitzer

Summary: Several RSV prevention strategies, including maternal immunization and long-lasting monoclonal antibodies (mAbs), show promise in preventing RSV hospitalizations in infants under 6 months of age. Live-attenuated vaccines can reduce hospitalizations in vaccinated age groups and have a modest effect in unvaccinated age groups as well.

NPJ VACCINES (2022)

No Data Available